Sugi Predict

Sugi Predict / Compounds / SCHEMBL294897

SCHEMBL294897

SCHEMBL294897

CCCCn1ccc(C)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ THRB P10828 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ NR1H3 Q13133 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ GAA P10253 3/20 0.37
▸ TLR8 Q9NR97 1/20 0.36
▸ TLR7 Q9NYK1 1/20 0.36
▸ CYP19A1 P11511 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292558 0.94 NPC1 (0.40) ALDH1A1POLBTHRBDRD2HTR2A
SCHEMBL9020965 0.92 NPC1 (0.42) ALDH1A1POLBTHRBMAPK1SMN1; SMN2
SCHEMBL9020584 0.92 NPC1 (0.42) ALDH1A1POLBTHRBMAPK1SMN1; SMN2
SCHEMBL17943853 0.92 NPC1 (0.42) ALDH1A1POLBTHRBMAPK1SMN1; SMN2
Hydrochloric Acid SCHEMBL31094672 0.90 NPC1 (0.41) ALDH1A1POLBTHRBTLR8MAPK1
SCHEMBL293669 0.87 — —
SCHEMBL1061779 0.82 HTR2A (0.40) ALDH1A1THRBTSHRDRD2HTR2A
SCHEMBL12954786 0.82 THRB (0.40) ALDH1A1THRBTSHRDRD2HTR2A
SCHEMBL19001353 0.79 THRB (0.38) ALDH1A1KMT2ATHRBDRD2HTR2A
SCHEMBL255119 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244421-A1 NOVEL COLORANT COMBINATION Henkel Kommanditgesellschaft auf Aktien (DE) 2002-10-02 — — EP claimed
WO-2001047484-A1 NOVEL COLORANT COMBINATION HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-07-05 — — WO claimed
CN-1045783-A Diaza  class anti-allergy medicament PFIZER (US) 1990-10-03 — — CN claimed
EP-4262718-A1 DYEING COMPOSITION BASED ON 2-GAMMA-HYDROXYPROPYL-PARA-PHENYLENEDIAMINE AND A PHOSPHORIC SURFACTANT L'OREAL (FR) 2023-10-25 — — EP disclosed
US-11504318-B2 Symmetric azomethine direct dyes, process for their preparation, cosmetic composition comprising at least one such dye and use thereof L'OREAL (FR) 2022-11-22 — — US disclosed
EP-4051209-A1 PROCESS FOR PREPARING A DYE COMPOSITION BY MIXING SOLID PARTICLES AND AN OXIDIZING COMPOSITION AND AN ALKALINE COMPOSITION L'OREAL (FR) 2022-09-07 — — EP disclosed
EP-4051210-A1 COATED COLOURING SOLID PARTICLES COMPRISING AT LEAST ONE DIRECT DYE AND/OR ONE OXIDATION DYE PRECURSOR L'OREAL (FR) 2022-09-07 — — EP disclosed
WO-2022129349-A1 DYEING COMPOSITION BASED ON 2-GAMMA-HYDROXYPROPYL-PARA-PHENYLENEDIAMINE AND A PHOSPHORIC SURFACTANT L'OREAL (FR) 2022-06-23 — — WO disclosed
WO-2021083904-A1 PROCESS FOR PREPARING A DYE COMPOSITION BY MIXING SOLID PARTICLES AND AN OXIDIZING COMPOSITION AND AN ALKALINE COMPOSITION L'OREAL (FR) 2021-05-06 — — WO disclosed
WO-2021083903-A1 COATED COLOURING SOLID PARTICLES COMPRISING AT LEAST ONE DIRECT DYE AND/OR ONE OXIDATION DYE PRECURSOR L'OREAL (FR) 2021-05-06 — — WO disclosed
EP-3087051-B1 BENZAMIDE AND NICOTINAMIDE COMPOUNDS AND METHODS OF USING SAME ONCOTARTIS INC (US) 2020-07-15 — — EP disclosed
US-20100016304-A1 GLUCOKINASE ACTIVATOR TEIJIN LIMITED (JP) 2010-01-21 — — US disclosed
US-20100016304-A1 GLUCOKINASE ACTIVATOR TEIJIN LIMITED (JP) 2010-01-21 — — US disclosed
WO-2009147170-A2 DRUG COMBINATIONS COMPRISING A DGAT INHIBITOR AND A PPAR-AGONIST JANSSEN PHARMACEUTICA NV (BE) 2009-12-10 — — WO disclosed
US-20090264404-A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-10-22 — — US disclosed
WO-2009077452-A1 METHOD FOR IMPROVING THE HYDROLYSIS STABILITY OF IONIC LIQUIDS BASF SE (DE) 2009-06-25 — — WO disclosed
WO-2009053127-A1 METHOD FOR THE CONTINUOUS PRODUCTION OF COLORING AGENTS FOR KERATINIC FIBERS HENKEL AG & CO. KGAA (DE) 2009-04-30 — — WO disclosed
CN-1743382-A Cationic diazo compounds, compositions comprising them as direct dye, process for dyeing keratin fibers and device therefor OREAL (FR) 2006-03-08 — — CN disclosed
US-20030000027-A1 Novel colorant combination HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2003-01-02 — — US disclosed
CN-1045783-A Diaza  class anti-allergy medicament PFIZER (US) 1990-10-03 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016304-A1 GLUCOKINASE ACTIVATOR GCK, GCKR, GALK1 ALDH1A1 1662/4885KMT2A 1681/4885POLB 4001/4885
US-20090264404-A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders GRIN2C, GRIN2B, PMP22 ALDH1A1 408/4885KMT2A 480/4885POLB 3667/4885
US-20030000027-A1 Novel colorant combination GPX4, PRDX3, NDUFS5 ALDH1A1 205/4885KMT2A 860/4885POLB 591/4885
US-11504318-B2 Symmetric azomethine direct dyes, process for their preparation, cosmetic composition comprising at least one such dye and use thereof KRT18, IK, H1-5 ALDH1A1 582/4885KMT2A 1000/4885POLB 1410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.